Labco has been offering HPV OncoTect, a cervical cancer test, on a limited basis since 2010.
The HPV OncoTect assay quantifies the overexpression of E6/E7 mRNA, the cancer-causing genes of HPV, in each cell and the total proportion of cells that are overexpressing E6/E7 mRNA.
IncellDx CEO Bruce Patterson said Labco is one of the largest laboratories in Europe and represents an important partner in their continued growth in Europe.